The effect of osteoporosis management on proximal humeral fracture

作者: Anshuman Singh , Annette L. Adams , Raoul Burchette , Richard M. Dell , Tadashi T. Funahashi

DOI: 10.1016/J.JSE.2014.07.005

关键词:

摘要: Hypothesis and background Proximal humeral fractures comprise 10% of in the Medicare population. The effect, if any, treating osteoporosis to prevent these has not been determined. primary objective is determine effectiveness a systematic screening treatment program on hazard developing fracture over period. secondary aim demographic risk factors. Methods This retrospective cohort study health care organization serving 3.3 million members. Individuals selected for dual-energy x-ray absorptiometry were (1) women aged 65 years or older; (2) men 70 years (3) individuals 50 years older who have history fragility fracture, use glucocorticoids, parental hip rheumatoid arthritis, alcohol at high rate, are cigarette smokers. Treatment consisted primarily pharmacologic intervention with bisphosphonates. Results diagnosed had ratio 7.43 sustaining Patients screened 0.17 whereas those treated medically 0.55 versus untreated controls. Risk factors that significantly increased included age, female gender, white race, diabetes mellitus, distal radius fracture. Discussion conclusion Over period, decreased proximal information broadens impact such programs because current best practices based prevention spine fractures.

参考文章(38)
E. D. Newman, W. T. Ayoub, R. H. Starkey, J. M. Diehl, G. C. Wood, Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporosis International. ,vol. 14, pp. 146- 151 ,(2003) , 10.1007/S00198-002-1336-5
KEVIN B. FREEDMAN, FREDERICK S. KAPLAN, WARREN B. BILKER, BRIAN L. STROM, ROBERT A. LOWE, Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*† Journal of Bone and Joint Surgery, American Volume. ,vol. 82, pp. 1063- 1070 ,(2000) , 10.2106/00004623-200008000-00001
J.H. Keyak, S. Sigurdsson, G. Karlsdottir, D. Oskarsdottir, A. Sigmarsdottir, S. Zhao, J. Kornak, T.B. Harris, G. Sigurdsson, B.Y. Jonsson, K. Siggeirsdottir, G. Eiriksdottir, V. Gudnason, T.F. Lang, Male–female differences in the association between incident hip fracture and proximal femoral strength: A finite element analysis study Bone. ,vol. 48, pp. 1239- 1245 ,(2011) , 10.1016/J.BONE.2011.03.682
B. Gullberg, O. Johnell, J.A. Kanis, World-wide Projections for Hip Fracture Osteoporosis International. ,vol. 7, pp. 407- 413 ,(1997) , 10.1007/PL00004148
O Sahap Atik, Izge Gunal, Feza Korkusuz, Burden of osteoporosis. Clinical Orthopaedics and Related Research. ,vol. 443, pp. 19- 24 ,(2006) , 10.1097/01.BLO.0000200248.34876.FE
Nancy Fox Ray, Julien K. Chan, Mae Thamer, L. Joseph Melton, Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation Journal of Bone and Mineral Research. ,vol. 12, pp. 24- 35 ,(1997) , 10.1359/JBMR.1997.12.1.24
J. Langley, A. Samaranayaka, G. Davie, A. J. Campbell, Age, cohort and period effects on hip fracture incidence: analysis and predictions from New Zealand data 1974-2007 Osteoporosis International. ,vol. 22, pp. 105- 111 ,(2011) , 10.1007/S00198-010-1205-6
Sun H Lee, Patricia Dargent‐Molina, Gérard Bréart, None, Risk Factors for Fractures of the Proximal Humerus: Results From the EPIDOS Prospective Study Journal of Bone and Mineral Research. ,vol. 17, pp. 817- 825 ,(2002) , 10.1359/JBMR.2002.17.5.817
Smita Nayak, Mark S. Roberts, Susan L. Greenspan, Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment PLoS ONE. ,vol. 7, pp. e32879- ,(2012) , 10.1371/JOURNAL.PONE.0032879